Additional effect of anthracycline in preoperative chemotherapy with a sequential anthracycline‑containing regimen preceded by pertuzumab, trastuzumab and docetaxel combination therapy

The proper use of anthracycline-containing regimens in combination with anti-HER2-targeted therapy in a neoadjuvant setting for patients with HER2-positive breast cancer has not been resolved. Regimens preceded by anthracyclines have become the standard of care, and although the order has no signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Hiroaki, Kutomi, Goro, Kuga, Yoko, Wada, Asaka, Satomi, Fukino, Sato, Kiminori, Kyuno, Daisuke, Nishikawa, Noriko, Uno, Satoko, Kameshima, Hidekazu, Ohmura, Tosei, Hasegawa, Tadashi, Takemasa, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798155/
https://www.ncbi.nlm.nih.gov/pubmed/36605524
http://dx.doi.org/10.3892/etm.2022.11767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798155/
https://www.ncbi.nlm.nih.gov/pubmed/36605524
http://dx.doi.org/10.3892/etm.2022.11767

Ejemplares similares